Skip to content

Tibial Nerve Stimulation in Chronic Functional Constipation

The Effect of Bilateral Transcutaneous Tibial Nerve Stimulation on Symptoms of Chronic Functional Constipation by Evaluation of Parasympathetic System through Hemodynamic Monitoring and Salivary Acetylcholinesterase Biomarker

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250812066839N1
Enrollment
30
Registered
2025-08-26
Start date
2025-09-11
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation. Constipation

Interventions

Intervention 1: Control group: Participants will receive conventional pelvic floor physiotherapy, which includes biofeedback using a rectal electrode for retraining and strengthening the anorectal mus

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Female participants aged 20 to 60 years who meet the Rome III criteria for chronic functional constipation

Exclusion criteria

Exclusion criteria: Currently receiving any other treatment for chronic functional constipation Previous treatment for chronic functional constipation within the past month Presence of any organic disorder known to cause constipation Diagnosis of neurological disorders (multiple sclerosis, Parkinson’s disease, or spinal cord injury) Presence of diabetic neuropathy Presence of congenital anomalies of the anorectal region Presence of anatomical disorders requiring surgical intervention (mucosal prolapse, rectocele, cystocele) as determined by a specialist Suffering from major depression (Beck Depression Inventory score > 30) Use of medications known to induce constipation (e.g., antidepressants, antihistamines, antiepileptic drugs) Previous anorectal surgery Current pregnancy or intention to become pregnant Prescence of periodontal disease

Design outcomes

Primary

MeasureTime frame
Salivary acetylcholine esterase. Timepoint: Baseline (prior to intervention), midpoint, and end of study. Method of measurement: Collection of unstimulated saliva sample and analysis using an acetylcholinesterase assay kit.;Hear Rate Variability. Timepoint: Baseline (prior to intervention), midpoint, and end of study. Method of measurement: Electrocardiography.

Secondary

MeasureTime frame
Clinical symptoms of chronic functional constipation. Timepoint: Baseline (prior to intervention), midpoint, and end of study. Method of measurement: Wexner constipation scoring system questionnaire.;Quality of life. Timepoint: Baseline (prior to intervention), midpoint, and end of study. Method of measurement: Patient Assessment of Constipation-Quality of Life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParnian Mirbehresi

Iran University of Medical Sciences

pbehresi@gmail.com+98 21 2222 2059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026